Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Acquisitions (2016 - 2023)

Historic Acquisitions for Fortress Biotech (FBIO) over the last 6 years, with Q1 2023 value amounting to -$5.0 million.

  • Fortress Biotech's Acquisitions rose 7500.0% to -$5.0 million in Q1 2023 from the same period last year, while for Jun 2024 it was -$5.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of -$20.0 million for FY2022, which is N/A changed from last year.
  • Per Fortress Biotech's latest filing, its Acquisitions stood at -$5.0 million for Q1 2023, which was up 7500.0% from -$20.0 million recorded in Q1 2022.
  • In the past 5 years, Fortress Biotech's Acquisitions ranged from a high of -$5.0 million in Q1 2023 and a low of -$20.0 million during Q1 2022